Quantcast

DrugRisk Pradaxa Lawsuit Update: Court Denys Boehringer’s Protective Order Request

January 31, 2013

The DrugRisk Resource Center is the Web´s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

Dallas, TX (PRWEB) January 31, 2013

The prescription drug information center DrugRisk.com is alerting those taking the blood thinner Pradaxa of updated information on the site regarding ongoing Pradaxa bleeding lawsuits. The judge presiding over the cases recently denied a request by the maker of the drug to hide prior charges of fraud.****

“The goal of DrugRisk is to improve patient safety through education of the latest drug warnings, recalls, studies and litigation news. By staying updated, patients can have informed discussions with their doctor and decide if they should seek legal advice,“ explains DrugRisk representative Ryan Mayer.

Reports on DrugRisk show that experts still disagree about Pradaxa bleeding risks. The FDA recently issued an update that the drug carries the same risks as warfarin.* However, the Americal College of Cardiology has warned that Pradaxa use can significantly increase the risk of bleeding complications compared to warfarin.**

Meanwhile, the resource center recently added a report from the Institute for Safe Medication Practices which ranks anticoagulants like Pradaxa among the highest risk outpatient drugs. The Institute also found that hemorrhage cases submitted to the FDA show bleeding from Pradaxa was nearly 5 times as likely to result in death than with warfarin.***

DrugRisk has learned that, due to the number of patients filing a Pradaxa lawsuit, they are being consolidated in a special federal court in Illinois, formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Now, new information on the site shows that Judge Herndon, who is overseeing the Pradaxa litigation, signed an order on January 19th denying attempts by Pradaxa maker Boehringer Ingelheim to protect information on prior lawsuits regarding false promotion, marketing or kickbacks for their drugs.****

Anyone affected by internal bleeding after taking Pradaxa is urged to speak with a lawyer about their legal options as soon as possible. Due to the specialized nature of federal drug injury cases, the Drug Risk Resource Center only recommends lawyers who are already handling Pradaxa lawsuits.

For more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*fda.gov/Drugs/DrugSafety/ucm326580.htm

** http://content.onlinejacc.org/article.aspx?articleid=1206384

***Instutute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf

****ilsd.uscourts.gov/opinions/ilsd_live.3.12.md.2385.2251290.0.pdf#search=%22pradaxa%22

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebpradaxa-litigation/pradaxa-lawsuits/prweb10374158.htm


Source: prweb



comments powered by Disqus